Bezafibrate improves insulin resistance evaluated using the glucose clamp technique in patients with type 2 diabetes mellitus: a small-scale clinical study-Reference-Cited by-同舟云学术

Bezafibrate improves insulin resistance evaluated using the glucose clamp technique in patients with type 2 diabetes mellitus: a small-scale clinical study

Published:2014-10-17 Issue:1 Volume:6 Page:
ISSN:1758-5996
Container-title:Diabetology & Metabolic Syndrome
language:en
Short-container-title:Diabetol Metab Syndr

Author:

Shiochi Hideki,Ohkura Tsuyoshi,Fujioka Yohei,Sumi Keisuke,Yamamoto Naoya,Nakanishi Risa,Matsuzawa Kazuhiko,Izawa Schoichiro,Ohkura Hiroko,Inoue Kazuoki,Ueta Etsuko,Kato Masahiko,Taniguchi Shin-ichi,Yamamoto Kazuhiro

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://link.springer.com/content/pdf/10.1186/1758-5996-6-113.pdf

Reference43 articles.

1. DeFronzo RA: Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes. 1988, 37: 667-687. 10.2337/diab.37.6.667.

2. The BIP Study Group: Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease the bezafibrate infarction prevention (BIP) study. Circulation. 2000, 102: 21-27.

3. Tenenbaum A, Motro M, Fisman EZ, Tanne D, Boyko V, Behar S: Bezafibrate for secondary prevention of myocardial infarction in patients with metabolic syndrome. Arch Intern Med. 2005, 165: 1154-1160. 10.1001/archinte.165.10.1154.

4. Tenenbaum A, Motro M, Fisman EZ, Adler Y, Shemesh J, Tanne D, Leor J, Boyko V, Schwammenthal E, Behar S: Effect of bezafibrate on incidence of type 2 diabetes mellitus in obese patients. Eur Heart J. 2005, 26: 2032-2038. 10.1093/eurheartj/ehi310.

5. Flory JH, Strom BL, Ellenberg S, Hennessy S, Szapary PO: Antidiabetic action of bezafibrate in a large observational database. Diabetes Care. 2009, 32 (4): 547-551. 10.2337/dc08-1809.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bezafibrate Exerts Neuroprotective Effects in a Rat Model of Sporadic Alzheimer’s Disease;Pharmaceuticals;2022-01-18

2. Effects of a novel selective peroxisome proliferator-activated receptor-α modulator, pemafibrate, on hepatic and peripheral glucose uptake in patients with hypertriglyceridemia and insulin resistance;Journal of Diabetes Investigation;2018-04-26

3. Effects of Pemafibrate, a Novel Selective PPARα Modulator, on Lipid and Glucose Metabolism in Patients With Type 2 Diabetes and Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial;Diabetes Care;2018-01-03

4. Triglyceride-Rich Lipoproteins and Novel Targets for Anti-atherosclerotic Therapy;Korean Circulation Journal;2018

5. Bezafibrate ameliorates diabetes via reduced steatosis and improved hepatic insulin sensitivity in diabetic TallyHo mice;Molecular Metabolism;2017-03